Edition:
United States

Prophase Labs Inc (PRPH.OQ)

PRPH.OQ on NASDAQ Stock Exchange Capital Market

2.26USD
11 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.26
Open
$2.28
Day's High
$2.28
Day's Low
$2.28
Volume
1
Avg. Vol
2,878
52-wk High
$2.37
52-wk Low
$1.78

Latest Key Developments (Source: Significant Developments)

ProPhase Labs quarterly loss per share $0.05 from continuing operations
Monday, 13 Nov 2017 08:30am EST 

Nov 13 (Reuters) - ProPhase Labs Inc :ProPhase Labs reports financial results for the three months and nine months ended September 30, 2017.Quarterly loss per share $0.05 from continuing operations.Quarterly sales $3.0 million versus $1.4 million.  Full Article

Prophase Labs intends to commence tender offer to repurchase up to 1.7 mln shares
Friday, 10 Nov 2017 08:06am EST 

Nov 10 (Reuters) - Prophase Labs Inc :Prophase Labs, Inc. announces intention to commence tender offer to repurchase up to 1,700,000 shares of its common stock.Prophase Labs Inc - ‍tender offer at a price per share of $2.30 per share​.Prophase Labs - ‍anticipates tender offer will be launched on or before Nov 20, 2017 and will remain open for at least 20 business days.  Full Article

BML Investment Partners reports 5.05 pct passive stake in ProPhase Labs
Monday, 2 Oct 2017 04:15pm EDT 

Oct 2 (Reuters) - Prophase Labs Inc :BML Investment Partners Lp reports 5.05 percent passive stake in ProPhase Labs Inc ‍​as of September 29 - SEC filing.  Full Article

ProPhase Labs, Inc. announces final results of its tender offer
Friday, 29 Sep 2017 08:30am EDT 

Sept 29 (Reuters) - Prophase Labs Inc :ProPhase Labs, Inc. Announces final results of its tender offer.ProPhase Labs Inc - ‍announced tender offer to purchase up to 4 million shares of its common stock at a price of $2.30/share.ProPhase Labs Inc - ‍accepted for purchase 4.3 million shares of its common stock for an aggregate purchase price of approximately $9.9 million​.  Full Article

ProPhase Labs CFO Robert Cuddihy to resign
Thursday, 24 Aug 2017 04:57pm EDT 

Aug 24 (Reuters) - ProPhase Labs Inc ::Says ‍on August 22, CFO Robert V. Cuddihy Jr., notified company of his intention to resign - SEC filing​.ProPhase Labs - ‍Cuddihy has agreed to continue in his employment with company and his role as CFO and chief accounting officer until Sept 29, 2017​.  Full Article

Prophase Labs Inc qtrly sales $1.9 million
Friday, 11 Aug 2017 08:00am EDT 

Aug 11 (Reuters) - Prophase Labs Inc :Prophase Labs reports financial results for the three months and six months ended June 30, 2017.Quarterly loss per share $0.09 from continuing operations.Quarterly sales $1.9 million versus $1.0 million.  Full Article

Prophase Labs repurchases 1,061,980 shares of its common stock
Tuesday, 13 Jun 2017 04:30pm EDT 

June 13 (Reuters) - Prophase Labs Inc : :Prophase Labs repurchases 1,061,980 shares of its common stock.Prophase Labs- Mark Leventhal, persons and entities associated with leventhal ceased to hold any direct or indirect ownership interest in co.Prophase Labs-anticipate incurring operating losses for foreseeable future related to costs incurred for cold-eeze business transition to unit of Mylan N.V..  Full Article

ProPhase Labs quarterly EPS $0.99 from continuing operations
Monday, 15 May 2017 08:30am EDT 

May 15 (Reuters) - ProPhase Labs Inc :ProPhase labs reports financial results for the three months ended March 31, 2017.Quarterly sales $771,000 versus $1.0 million.Quarterly earnings per share $0.99 from continuing operations.  Full Article

ProPhase provides shareholder update
Wednesday, 5 Apr 2017 04:10pm EDT 

ProPhase Labs Inc : ProPhase provides shareholder update . ProPhase Labs Inc- Company received net proceeds from sale of cold-eeze(®) of approximately $39.3 million after certain deductions .ProPhase Labs - Anticipates co's cash resources to be further reduced as consequence of required payments of co's retained liabilities, among others.  Full Article

Prophase labs announces agreement to sell cold-eeze(r) brand
Monday, 9 Jan 2017 07:30am EST 

Prophase Labs Inc : Prophase labs announces agreement to sell cold-eeze(r) brand . Deal for $50 million . Mylan will purchase substantially all of company's assets and other rights relating to cold-eeze cold remedy brand . As part of transaction, company, through its Pharmaloz subsidiary, will enter into a manufacturing and supply agreement with Mylan .As part of transaction, company, through its Pharmaloz subsidiary, will enter into a manufacturing and supply agreement with Mylan.  Full Article

BRIEF-ProPhase Labs quarterly loss per share $0.05 from continuing operations

* ProPhase Labs reports financial results for the three months and nine months ended September 30, 2017

No consensus analysis data available.